Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(1):e30647.
doi: 10.1371/journal.pone.0030647. Epub 2012 Jan 27.

Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study

Vichet Phan  1 , Sopheak Thai, Kimcheng Choun, Lutgarde Lynen, Johan van Griensven
Affiliations

Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study

Vichet Phan et al. PLoS One. 2012.

Abstract

Background: Although stavudine (D4T) remains frequently used in low-income countries in Asia, associated long-term toxicity data are scarce. The aim of this study was to determine the long-term incidence of severe D4T-toxicity (requiring drug substitution) and associated risk factors in HIV-infected Cambodians up to six years on antiretroviral treatment (ART).

Methodology/principal findings: This is a retrospective analysis of an observational cohort, using data from an ART program with systematic monitoring for D4T-toxicity. Probabilities of time to D4T substitution due to suspected D4T toxicity (treatment-limiting D4T toxicity) were calculated, a risk factor analysis was performed using multivariate Cox regression modelling. Out of 2581 adults initiating a D4T-containing regimen, D4T was replaced in 276 (10.7%) patients for neuropathy, 14 (0.5%) for lactic acidosis and 957 (37.1%) for lipoatrophy. The main early side effect was peripheral neuropathy (7.0% by 1 year). After the first year, lipoatrophy became predominant, with a cumulative incidence of 56.1% and 72.4% by 3 and 6 years respectively. Older age (aHR 1.8; 95%CI: 1.4-2.3) and lower baseline haemoglobin (aHR 1.7; 95%CI: 1.4-2.2) were associated with the occurrence of neuropathy. Being female (aHR 3.8; 95%CI: 1.1-12.5), a higher baseline BMI (aHR 12.6; 95%CI: 3.7-43.1), and TB treatment at ART initiation (aHR 8.6; 95%CI: 2.7-27.5) increased the likelihood of lactic acidosis. Lipoatrophy was positively associated with female gender (aHR 2.3; 95%CI: 2.0-2.6), an older age (aHR 1.3; 95%CI: 1.1-1.4), and a CD4 count <200 cells/µL (aHR 1.3; 95%CI: 1.1-1.5).

Conclusions: Stavudine-based treatment regimens in low-income countries are associated with significant long-term toxicities, predominantly lipoatrophy. Close clinical monitoring for toxicity with timely D4T substitution is recommended. Phasing-out of stavudine should be implemented, as costs allows.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Cumulative incidence of lipoatrophy.
Kaplan-Meier curve showing the proportion of patients substituting stavudine due to lipoatrophy.
See this image and copyright information in PMC

References

    1. World Health Organization. Towards universal access: scaling up priority HIV/AIDS intervention in the health sector: Progress report, September 2009. 2009. Available: http://www.who.int/hiv/pub/2009progressreport/en/
    1. Womack J. HIV-related lipodystrophy in Africa and Asia. AIDS Read. 2009;19:131–152. - PubMed
    1. World Health Organization. Scaling up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a Public Health Approach: 2003 Revision. 2004. Available: http://www.who.int/3by5/publications/documents/arv_guidelines/en/
    1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach: 2006 Revision. 2006. Available: http://www.who.int/hiv/events/artprevention/gilks.pdf. - PubMed
    1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents, Recommendations for a public health approach, 2010 revision. 2010. Available: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf. - PubMed

Publication types